Clinical significance of CYP2C9‐status guided valproic acid therapy in children

Publisher： John Wiley & Sons Inc

E-ISSN： 1528-1167|56|6|849-855

ISSN： 0013-9580

Source： EPILEPSIA, Vol.56, Iss.6, 2015-06, pp. : 849-855

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The CYP2C9 polymorphism: from enzyme kinetics to clinical dose recommendations

By Kirchheiner Julia   Tsahuridu Martina   Jabrane Wafaa   Roots Ivar   Brockmööller Jüürgen  

Personalized Medicine, Vol. 1, Iss. 1, 2004-12 ,pp. : 63-84

Future Medicine

Access to resources Recommend Favorite

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and HLA‐B Genotypes and Phenytoin Dosing

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 5, 2014-11 ,pp. : 542-548

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dicloxacillin induces CYP2C19, CYP2C9 and CYP3A4 in vivo and in vitro

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 84, Iss. 3, 2018-03 ,pp. : 510-519

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 103, Iss. 2, 2018-02 ,pp. : 349-349

John Wiley & Sons Inc

Access to resources Recommend Favorite

Influence of CYP2C9 polymorphism on the fall in International Normalized Ratio in patients interrupting warfarin therapy before elective surgery

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 8, 2015-08 ,pp. : 1436-1440

John Wiley & Sons Inc

Access to resources Recommend Favorite